FDA Clearance Tracker · P040012-S056
RX ACCULINK CAROTID STENT SYSTEM
Last checked: Nov 20, 2026Latest source record: Mar 4, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Mar 4, 2016
Approved
Time to decision
60 days
Received Jan 4, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040012-S056
- Device name
- RX ACCULINK CAROTID STENT SYSTEM
- Applicant
- Abbott Vascular
- Applicant location
- Santa Clara, CA
- Received
- Jan 4, 2016
- Decided
- Mar 4, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P040012
Device type
- Device type
- Stent, carotid (NIM)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of the following changes to the post-approval study for the device:request to modify the conditions of approval follow-up requirement from 3 to 2 years.
Source documents
Other decisions for Abbott Vascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- XACT Carotid Stent SystemPMA supplement
P040038-S043 · Decided Feb 7, 2024 · 225 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.